Spartanburg Regional Healthcare System (SRHS) Selects AccessDx Laboratory as Pharmacogenomics (PGx) Program Partner

Collaboration empowers clinicians with personalized insights and furthers health equity in precision medicine

SPARTANBURG, S.C. and HOUSTON, July 2, 2025 /PRNewswire/ --  Spartanburg Regional Healthcare System (SRHS) has selected AccessDx Laboratory as its partner to power a comprehensive pharmacogenomics (PGx) program. SRHS will collaborate with AccessDx Laboratory to offer employees and patients PGx testing, enabling clinicians to identify potentially dangerous drug-gene interactions, improve medication efficacy, and deliver better patient outcomes.

SRHS selected AccessDx Laboratory based on its high-evidence, comprehensive approach to PGx through multispecialty comprehensive panels, its commitment to health equity through analysis of rare genetic variants, and its ability to seamlessly integrate lab results directly into their EHR.

"We are excited to expand AccessDx Laboratory's presence in the hospital market and support SRHS's focus on optimizing patient care," said Bryon Cipriani, CEO of AccessDx Laboratory and its parent company, Aranscia. "PGx testing benefits patients in all stages of their care journeys, throughout their lifetimes, and across the continuum of care. SRHS distinguishes itself through its embrace of precision medicine across all care disciplines, evidenced by its commitment to helping deliver discrete drug-gene insights at providers' fingertips and supporting effective utility with educational resources and publications."

SRHS will leverage AccessDx Laboratory's experts and their wealth of drug-gene knowledge and research findings to educate clinical leaders, care teams, patients, and communities through a combination of expert content and supplemental training courses. SRHS will collaborate with industry leaders to deploy and expand upon proven, peer-reviewed strategies and guidelines for pre-emptive risk assessment, selective testing, and point-of-care insight delivery. The program's goal is to see both patients and providers benefit from PGx's lifelong value in guiding specific treatment options.

"AccessDx Laboratory shares our commitment to health equity and improving patient outcomes and has the most comprehensive set of PGx resources available, making it an ideal partner," said Charles Morrow, MD, Executive Vice President and Chief Operating Officer, SRHS. "This collaboration enables SRHS clinicians to deliver better care to those within our community and ensures local residents can benefit from impactful, precision medicine-based treatments in their own hospital/care center, without having to travel elsewhere."

As part of a broader set of precision medicine initiatives at SRHS, the PGx program will initially be launched in family practice, oncology, maternal-fetal medicine, behavioral health, and pediatrics settings, with availability across all clinical specialties targeted for 2025. PGx insights will also be incorporated in SRHS's deployment of 2bPrecise^® Enterprise, further reinforcing SRHS's commitment to precision medicine and enhancing the utility of PGx insights across its facilities.

About Spartanburg Regional Healthcare System

Founded in 1917, Spartanburg Regional Healthcare System (SRHS) is an integrated healthcare delivery system and one of the largest providers of regional care in South Carolina.  With a mission of advancing health together, SRHS' footprint includes over six hospital campuses and 150 offices, and employs more than 10,000 associates and 700 physicians. For more, visit https://spartanburgregional.com.

About AccessDx Laboratory

AccessDx Laboratory, an Aranscia™ company, is a CLIA-certified, CAP-accredited, and NYSDOH-approved diagnostic laboratory dedicated to providing clinical insights that help improve patient outcomes.  AccessDx solutions include pharmacogenomics (PGx) testing, cancer genomic (CGX) testing, infectious disease testing, and a wide range of clinical laboratory research, development, and consultancy services.  With demonstrated commitments to clinical and analytical excellence, turnaround time, and high-throughput operations and support infrastructure, millions of AccessDx Laboratory tests have been trusted by thousands of health systems, care providers, employer groups, and municipalities nationwide. To learn more, visit www.accessdxlab.com. 

Media Contact

Karina Stabile
Aria Marketing for AccessDx
(516) 317-5835
[email protected] 

SOURCE AccessDx Laboratory